Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Should surface photodynamic therapy be used for skin neoplasms].

× No keyword cloud information.

11 in total

1. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial.

Authors: Ymke G L de Graaf; Cornelis Kennedy; Ron Wolterbeek; Annemie F S Collen; Rein Willemze; Jan N Bouwes Bavinck
Journal: J Invest Dermatol Date: 2006-03 Impact factor: 8.551

2. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

Authors: Lasse R Braathen; Rolf-Markus Szeimies; Nicole Basset-Seguin; Robert Bissonnette; Peter Foley; David Pariser; Rik Roelandts; Ann-Marie Wennberg; Colin A Morton
Journal: J Am Acad Dermatol Date: 2007-01 Impact factor: 11.527

Review 3. Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy.

Authors: J Fuchs; S Weber; R Kaufmann
Journal: Free Radic Biol Med Date: 2000-02-15 Impact factor: 7.376

4. Multiple large-surface photodynamic therapy sessions with topical or systemic aminolevulinic acid and blue light in UV-exposed hairless mice.

Authors: Younan Liu; Gilles Viau; Robert Bissonnette
Journal: J Cutan Med Surg Date: 2004-05-04 Impact factor: 2.092

5. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice.

Authors: I M Stender; N Bech-Thomsen; T Poulsen; H C Wulf
Journal: Photochem Photobiol Date: 1997-10 Impact factor: 3.421

6. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients.

Authors: Hans Christian Wulf; Stan Pavel; Ida Stender; Christianne Ahb Bakker-Wensveen
Journal: Acta Derm Venereol Date: 2006 Impact factor: 4.437

7. Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice.

Authors: V Caty; Y Liu; G Viau; R Bissonnette
Journal: Br J Dermatol Date: 2006-04 Impact factor: 9.302

8. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets.

Authors: Ya-Ju Hsieh; Chih-Ching Wu; Cheng-Jen Chang; Jau-Song Yu
Journal: J Cell Physiol Date: 2003-03 Impact factor: 6.384

9. Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice.

Authors: Soraya Sharfaei; Petras Juzenas; Johan Moan; Robert Bissonnette
Journal: Arch Dermatol Res Date: 2002-06-26 Impact factor: 3.017

10. Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo.

Authors: L E Finlan; N M Kernohan; G Thomson; P E Beattie; T R Hupp; S H Ibbotson
Journal: Br J Dermatol Date: 2005-11 Impact factor: 9.302